Y-mAbs(YMAB) - 2022 Q4 - Earnings Call Transcript
YMABY-mAbs(YMAB)2023-03-31 23:08

Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q4 2022 Earnings Conference Call March 31, 2023 9:00 AM ET Company Participants Thomas Gad - Founder, Interim CEO & President Sue Smith - SVP & Chief Commercial Officer Bo Kruse - EVP, Secretary, Treasurer & CFO Vignesh Rajah - Chief Medical Officer Conference Call Participants Alec Stranahan - Bank of America Etzer Darout - BMO Capital Markets William Maughan - Canaccord Genuity Taylor Hanley - JPMorgan Edouard Mullarky - Guggenheim Securities Operator Good mornin ...